**Author details**

Kinda Al-Hourani1 , Jessica Lee Siew Hua<sup>2</sup> and Parijat De3 \*

1 Haematology, NHS Greater Glasgow and Clyde, UK


\*Address all correspondence to: p.de@nhs.net

© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/ by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

**73**

*Investigation and Management of Endocrinopathies in Thalassaemia Major*

Archives of Disease in Childhood. 1983

[8] De Sanctis V, Vullo C, Katz M, Atti G, Capra L, Di Palma A, et al. Endocrine complications in thalassaemia major. In: In advances and controversies in thalassaemia therapy. New York, NY, US: Alan R. Liss, Inc. (Publishers); 1989.

[9] Tiosano D, Hochberg Z. Endocrine complications of thalassaemia. Journal of Endocrinological Investigation. 2001

Feb;**58**(2):120-127

Oct 1;**24**(9):716-723

[10] Theodoridis C, Ladis V, Papatheodorou A, Berdousi H, Palamidou F, Evagelopoulou C, et al. Growth and management of short stature in thalassaemia major. Journal of Pediatric Endocrinology & Metabolism.

1998;**11**(Suppl 3):835-844

PMCID: PMC5937976.

1):72-79

Apr;**31**(2):83-87

[11] Dhouib NG, Ben Khaled M, Ouederni M, Besbes H, Kouki R, Mellouli F, Bejaoui M. Growth and Endocrine Function in Tunisian Thalassemia Major Patients. Mediterr J Hematol Infect Dis. 2018 May 1;10(1):e2018031. doi: 10.4084/ MJHID.2018.031. PMID: 29755708;

[12] De Sanctis V. Growth and puberty and its management in thalassaemia. Hormone Research. 2002;**58**(Suppl

[13] Kwan E, Lee A, Li A, Tam S, Chan C, Lau Y, et al. A cross-sectional study of growth, puberty and endocrine function in patients with thalassaemia major in Hong Kong. Journal of paediatrics and child health. 1995

[14] Raiola G, Galati MC, De

Sanctis V, Caruso Nicoletti M, Pintor C, De Simone M, et al. Growth and puberty

p. 77-83.

*DOI: http://dx.doi.org/10.5772/intechopen.93861*

[1] Shamshirsaz AA, Bekheirnia MR, Kamgar M, Pourzahedgilani N, Bouzari N, Habibzadeh M, et al. Metabolic and endocrinologic complications in betathalassaemia major: A multicenter study in Tehran. BMC Endocrine Disorders.

2003 Aug 12;**3**(1):4

**References**

[2] Al-Elq AH, Al-Saeed HH. Endocrinopathies in patients with thalassaemias. Saudi Medical Journal.

2004 Oct;**25**(10):1347-1351

[3] Bannerman RM, Keusch G, Kreimer-Birnbaum M, Vance VK, Vaughan S. Thalassemia intermedia, with iron overload, cardiac failure, diabetes mellitus, hypopituitarism and porphyrinuria. The American Journal of Medicine. 1967 Mar;**42**(3):476-486

[4] Cappellini M-D, Cohen A,

of Thalassaemia: Thalassaemia

for the Clinical Management of Thalassaemia [Internet]. 2nd Revised. Nicosia (CY): Thalassaemia International Federation; 2008 [cited 2020 May 9]. p. 41-9. Available from: http://www.ncbi.nlm.nih.gov/books/

NBK173968/

May;**133**(5):497-502

Eleftheriou A, Piga A, Porter J, Taher A. Guidelines for the Clinical Management

International Federation. In: Guidelines

[5] Costin G, Kogut MD, Hyman CB, Ortega JA. Endocrine abnormalities in thalassaemia major. American Journal of Diseases of Children. 1979

[6] Brezis M, Shalev O, Leibel B, Bernheim J, Ben-Ishay D. Phosphorus retention and hypoparathyroidism associated with transfusional iron overload in thalassaemia. Mineral and Electrolyte Metabolism. 1980;**4**:57-61

[7] Sabato AR, de Sanctis V, Atti G, Capra L, Bagni B, Vullo C. Primary hypothyroidism and the low T3 syndrome in thalassaemia major.

*Investigation and Management of Endocrinopathies in Thalassaemia Major DOI: http://dx.doi.org/10.5772/intechopen.93861*
